1. Home
  2. MRVI vs TRAK Comparison

MRVI vs TRAK Comparison

Compare MRVI & TRAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • TRAK
  • Stock Information
  • Founded
  • MRVI 2014
  • TRAK 1990
  • Country
  • MRVI United States
  • TRAK United States
  • Employees
  • MRVI N/A
  • TRAK N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • TRAK EDP Services
  • Sector
  • MRVI Health Care
  • TRAK Technology
  • Exchange
  • MRVI Nasdaq
  • TRAK Nasdaq
  • Market Cap
  • MRVI 312.4M
  • TRAK 374.5M
  • IPO Year
  • MRVI 2020
  • TRAK 1998
  • Fundamental
  • Price
  • MRVI $2.20
  • TRAK $16.69
  • Analyst Decision
  • MRVI Hold
  • TRAK
  • Analyst Count
  • MRVI 10
  • TRAK 0
  • Target Price
  • MRVI $6.84
  • TRAK N/A
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • TRAK 51.2K
  • Earning Date
  • MRVI 08-11-2025
  • TRAK 09-29-2025
  • Dividend Yield
  • MRVI N/A
  • TRAK 0.44%
  • EPS Growth
  • MRVI N/A
  • TRAK 21.41
  • EPS
  • MRVI N/A
  • TRAK 0.34
  • Revenue
  • MRVI $241,856,000.00
  • TRAK $22,028,373.00
  • Revenue This Year
  • MRVI N/A
  • TRAK $15.18
  • Revenue Next Year
  • MRVI $10.70
  • TRAK $10.00
  • P/E Ratio
  • MRVI N/A
  • TRAK $48.66
  • Revenue Growth
  • MRVI N/A
  • TRAK 9.73
  • 52 Week Low
  • MRVI $1.67
  • TRAK $15.12
  • 52 Week High
  • MRVI $9.95
  • TRAK $25.01
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 42.78
  • TRAK 34.97
  • Support Level
  • MRVI $1.99
  • TRAK $15.58
  • Resistance Level
  • MRVI $2.40
  • TRAK $16.89
  • Average True Range (ATR)
  • MRVI 0.16
  • TRAK 0.68
  • MACD
  • MRVI -0.06
  • TRAK -0.03
  • Stochastic Oscillator
  • MRVI 25.15
  • TRAK 46.03

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About TRAK ReposiTrak Inc.

ReposiTrak Inc is a software as a service provider with extensive capabilities that gives their customers an easy, cost-efficient way to expand their services to their benefit. The company and its subsidiaries develop, market, and support proprietary software products. These products assist the management of business operations, which helps clients to make more informed decisions. The company also provides a cloud-based solution to remain in compliance with business records and regulatory requirements. The firm's services comprise implementation, business optimization, outsourcing, technical services, education, and application hosting.

Share on Social Networks: